Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ramos

Showing results (571-580 of 606) with videos related to

Pageof 61
Sort By:
Microbial Pathogenesis|June 3, 2020
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Grasiele S V Tavares, et al.
Parasitology Research|October 19, 2021
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfectionNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Microbial Pathogenesis|December 9, 2021
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteinsNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Nature|August 23, 2019
Microbiota-derived lantibiotic restores resistance against vancomycin-resistant EnterococcusSohn G Kim, Simone Becattini, Thomas U Moody, et al.
Microbial Pathogenesis|May 5, 2022
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasisDanniele L Vale, Amanda S Machado, Fernanda F Ramos, et al.
Parasite (Paris, France)|May 1, 2020
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine modelGrasiele S V Tavares, Débora V C Mendonça, Isabela A G Pereira, et al.
Molecular Immunology|June 26, 2020
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasisJoão A Oliveira-da-Silva, Daniela P Lage, Fernanda F Ramos, et al.
Experimental Parasitology|December 30, 2021
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary studyDébora V C Mendonça, Grasiele S V Tavares, Isabela A G Pereira, et al.
Experimental Parasitology|July 6, 2020
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human diseaseAmanda S Machado, Fernanda F Ramos, Thaís T O Santos, et al.
Acta Tropica|September 19, 2021
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary studyThaís T O Santos, Fernanda F Ramos, Isabela A P Gonçalves, et al.
Pageof 61

Showing results (571-580 of 606) with videos related to

Sort By:
Pageof 61
Microbial Pathogenesis|June 3, 2020
Biotechnological applications from a Leishmania amastigote-specific hypothetical protein in the canine and human visceral leishmaniasisJoão A Oliveira-da-Silva, Amanda S Machado, Grasiele S V Tavares, et al.
Parasitology Research|October 19, 2021
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfectionNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Microbial Pathogenesis|December 9, 2021
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteinsNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Nature|August 23, 2019
Microbiota-derived lantibiotic restores resistance against vancomycin-resistant EnterococcusSohn G Kim, Simone Becattini, Thomas U Moody, et al.
Microbial Pathogenesis|May 5, 2022
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasisDanniele L Vale, Amanda S Machado, Fernanda F Ramos, et al.
Parasite (Paris, France)|May 1, 2020
A clioquinol-containing Pluronic<sup>®</sup> F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine modelGrasiele S V Tavares, Débora V C Mendonça, Isabela A G Pereira, et al.
Molecular Immunology|June 26, 2020
Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasisJoão A Oliveira-da-Silva, Daniela P Lage, Fernanda F Ramos, et al.
Experimental Parasitology|December 30, 2021
Flau-A, a naphthoquinone derivative, is a promising therapeutic candidate against visceral leishmaniasis: A preliminary studyDébora V C Mendonça, Grasiele S V Tavares, Isabela A G Pereira, et al.
Experimental Parasitology|July 6, 2020
A new Leishmania hypothetical protein can be used for accurate serodiagnosis of canine and human visceral leishmaniasis and as a potential prognostic marker for human diseaseAmanda S Machado, Fernanda F Ramos, Thaís T O Santos, et al.
Acta Tropica|September 19, 2021
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary studyThaís T O Santos, Fernanda F Ramos, Isabela A P Gonçalves, et al.
Pageof 61